Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey.
作者信息
Khan Zakir, Karatas Yusuf
机构信息
Institute of Health Sciences, Department of Medical Pharmacology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Department of Medical Pharmacology, Pharmacovigilance Specialist, Faculty of Medicine, Balcali Hospital, Cukurova University, Adana, Turkey.
出版信息
J Taibah Univ Med Sci. 2022 Feb 18;17(2):340-342. doi: 10.1016/j.jtumed.2021.12.009. eCollection 2022 Apr.
Abstract
摘要
相似文献
1
Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey.十多年来的药品不良反应报告：土耳其实施药物警戒政策的必要性。
J Taibah Univ Med Sci. 2022 Feb 18;17(2):340-342. doi: 10.1016/j.jtumed.2021.12.009. eCollection 2022 Apr.
2
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.土耳其医疗保健专业人员对药物警戒和药品不良反应报告的知识、态度、实践及障碍：一项系统综述
Curr Med Res Opin. 2022 Jan;38(1):145-154. doi: 10.1080/03007995.2021.1997287. Epub 2021 Nov 3.
3
An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey.土耳其护士和助产士的药物警戒知识评估。
Indian J Pharmacol. 2013 Nov-Dec;45(6):616-8. doi: 10.4103/0253-7613.121375.
4
Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.评估医疗保健专业人员在药物警戒和药物不良反应报告方面的知识、态度、实践和障碍：一项跨中心的横断面研究。
PLoS One. 2023 May 24;18(5):e0285811. doi: 10.1371/journal.pone.0285811. eCollection 2023.
5
Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital.土耳其卫生专业人员在一所大学医院对药物警戒的知识、态度和实践。
Int Health. 2019 May 1;11(3):177-184. doi: 10.1093/inthealth/ihy073.
6
Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.沙特阿拉伯达曼医疗保健人员对药物警戒及药品不良反应报告流程的知识、实践与态度
Curr Drug Saf. 2018;13(1):21-25. doi: 10.2174/1574886313666171218123802.
7
The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.土耳其社区药剂师对伊斯坦布尔卡迪科伊区药物警戒的知识和态度。
Pharm World Sci. 2008 Oct;30(5):556-62. doi: 10.1007/s11096-008-9209-4. Epub 2008 Mar 19.
8
Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.尼日利亚门诊患者对不良反应的知识、意识、看法和报告。
Int J Clin Pharm. 2019 Aug;41(4):1062-1073. doi: 10.1007/s11096-019-00849-9. Epub 2019 May 28.
9
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.埃及医生和药剂师在药物警戒和药物不良反应报告方面的知识、态度和实践：迈向个体化医学实施的一步。
Per Med. 2022 Nov;19(6):495-507. doi: 10.2217/pme-2022-0030. Epub 2022 Oct 14.
10
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.2011 - 2014年四年间意大利南部卡拉布里亚地区的药品不良反应报告：鉴于新的欧洲立法，一项地区药物警戒项目的影响
Expert Opin Drug Saf. 2017 May;16(5):515-522. doi: 10.1080/14740338.2017.1316486. Epub 2017 Apr 19.
引用本文的文献
1
Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.评估医疗保健专业人员在药物警戒和药物不良反应报告方面的知识、态度、实践和障碍：一项跨中心的横断面研究。
PLoS One. 2023 May 24;18(5):e0285811. doi: 10.1371/journal.pone.0285811. eCollection 2023.
本文引用的文献
1
The value of direct patient reporting in pharmacovigilance.直接患者报告在药物警戒中的价值。
Ther Adv Drug Saf. 2020 Oct 26;11:2042098620940164. doi: 10.1177/2042098620940164. eCollection 2020.
2
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.土耳其医疗保健专业人员对药物警戒和药品不良反应报告的知识、态度、实践及障碍：一项系统综述
Curr Med Res Opin. 2022 Jan;38(1):145-154. doi: 10.1080/03007995.2021.1997287. Epub 2021 Nov 3.
3
Adverse Drug Reaction Reporting by Patients in 12 European Countries.患者在 12 个欧洲国家的药物不良反应报告。
Int J Environ Res Public Health. 2021 Feb 5;18(4):1507. doi: 10.3390/ijerph18041507.
4
Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education.土耳其药品不良反应报告及障碍：对药物警戒教育的迫切需求。
Ther Adv Drug Saf. 2020 May 7;11:2042098620922483. doi: 10.1177/2042098620922483. eCollection 2020.
5
Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action.加强欧盟监管网络中的药物警戒能力：SCOPE 联合行动。
Drug Saf. 2018 Dec;41(12):1285-1302. doi: 10.1007/s40264-018-0708-5.
6
Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation.土耳其药品不良反应报告模式：基于首部药物警戒法规对国家数据库的分析
Drugs Real World Outcomes. 2016 Mar;3(1):33-43. doi: 10.1007/s40801-015-0054-1.
7
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.药物警戒教学：世界卫生组织-国际药物警戒学会综合模块化课程的核心要素
Drug Saf. 2014 Oct;37(10):743-59. doi: 10.1007/s40264-014-0216-1.
8
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.全球范围内十年来药物不良反应模式分析：来自 VigiBase™ 的自发报告
Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.1007/BF03262002.
Zotero 插件